摘要:
The application relates to novel amino alcohols of the general formula (I) where R, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 each have the definitions illustrated in detail in the description, to a process for their preparation, and to the use of these compounds as medicines, in particular as renin inhibitors.
摘要:
The present application describes modulators of MCP-1 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis.
摘要:
Racemic or enantiomerically pure 4-pyrrolidino derivatives of formula (I), processes for their preparation, pharmaceutical compositions comprising said derivatives, and their use in the prevention and treatment of illness, e.g. which are mediated by monoamine oxidase B inhibitors, in particular Alzheimer's disease or senile dementia.
摘要:
Es werden substituierte 3-Heteroaryl(amino-oder oxy)-pyrrolidin-2-one der allgemeinen Formel (I), Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide oder als Pflanzenwachstumsregulatoren beschrieben: In der allgemeinen Formel (I) stehen A für ein unsubstituiertes oder substituiertes Aryl; B für eine direkte Bindung oder eine divalente Einheit, V beispielsweise für CH 2 , S, oder O; W für O, S, oder H 2 ; Q für eine substituierte oder unsubstituierte Brücke und D für eine unsubstituiertes oder substituiertes C 6 -Aryl oder Heteroaryl. R 1 und R 2 stehen für verschiedene Reste.
摘要:
Processes for the preparation of pyrrolidones (7 and 8) and pyrrolidines (9 and 10) from tri-O-acetyl-D- erythro -4-pentulosonic acid esters are described. The compounds are aza sugar analogs of D-ribofuranoside and are intermediates to drugs which regulate nucleoside and nucleic acid synthesis.
摘要:
A method for preparing an N-[(aliphatic or aromatic)carbonyl)]-2-aminoacetamide compound, and for preparing a cyclized compound therefrom, as well as novel resin bound intermediate compounds that are useful for preparing such compounds.
摘要:
Compounds represented by general formula (1) or salts thereof which have a matrix metalloprotease inhibitory activity and are useful as drugs, wherein the rings A and B represent each an optionally substituted homocycle or heterocycle, etc.; R s are the same or different and each represents hydrogen, optionally substituted hydrocarbyl, acyl, etc.; X represents a bond, optionally substituted divalent aliphatic hydrocarbyl, etc.; X represents a bond, optionally substituted divalent aliphatic hydrocarbyl, -O-, etc.; Ys are the same or different and each represents hydrogen, optionally substituted hydrocarbyl, oxo, etc.; m is 0 or 1; n is an integer of 1 to 3; q1 is an integer of 1 to 2n+4; and q2 is an integer of 0 to 2n+3, provided that q1+q2 is 2n+4.
摘要翻译:由通式(1)表示的化合物或其盐具有基质金属蛋白酶抑制活性,可用作药物,其中环A和B各自表示任选取代的杂环或杂环等; R 1相同或不同,各自表示氢,任选取代的烃基,酰基等; X 1表示键,任选取代的二价脂族烃基等; X 2代表键,任选取代的二价脂族烃基,-O-等; Y相同或不同,各自表示氢,任选取代的烃基,氧代等; m为0或1; n为1〜3的整数, q1为1〜2n + 4的整数, 并且q2为0〜2n + 3的整数,条件是q1 + q2为2n + 4。
摘要:
The invention concerns a novel chemical process for the manufacture of methyl (2 S )-2-[3 R )-3-( N -[ tert -butyloxycarbonyl]amino)-2-oxopyrrolidin-1-yl]propionate.
摘要:
The present invention relates to processes for the enantioselective synthesis of hydroxypyrrolidines from amino acids. An amino methyl ester is used as the starting material. The ester is reacted with a benziminoethyl ether to produce an oxazoline or thiazoline. Specifically, L-serine methyl ester is used to produce 4-(carbomethoxy)-2-phenyl- DELTA -oxazoline, and cysteine is used to produce the corresponding thiazoline. The oxazoline (or thiazoline) can be reduced to an aldehyde by treatment with a slight excess of DIBAL-H. The oxazoline is quenched with alcohol and reacted with (carbomethoxymethylene) triphenylphosphorane, to produce (S)-(+)-methyl (E)- and (S)-(-)-methyl (Z)-3-(4,5-dihydro-2-phenyl-4-oxazolyl)-2-propenoate. The double bond is hydroxylated to yield the diol esters. The resulting diol is then treated with aqueous acid to hydrolyze the oxazoline and recyclize to produce 3,4-dihydroxy-5-hydroxymethylpyrrolidone benzoate. This is treated with an excess of borane in tetrahydrofuran to yield (2-hydroxymethyl) 3,4-dihydroxypyrrolidine. The intermediate compounds are useful both in the present process and as final products themselves. The total yield of the mixture of isomers, as well as their ratio, can be varied.